Company Overview and News

 
Asian markets mostly lower after Wall Street gains

35m nzherald.co.nz
BEIJING (AP) — Asian markets were mostly lower Tuesday after Wall Street gained as Italy moved toward forming a euroskeptic-led government.

 
PRESS DIGEST-New York Times business news - May 22

46m reuters
May 22 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy.

 
This Dog Of The Dow Is No Mutt

1h seekingalpha
There still is potential for growth by increase consumption of Coca-Cola products in places like China and India.

 
PRESS DIGEST -Wall Street Journal - May 22

1h reuters
May 22 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.

 
Wall Street rises on trade war truce; industrials lead

1h thehindubusinessline
US stocks rose on Monday and gains in industrials helped propel the Dow to a more than two-month closing high, after a truce between the United States and China calmed fears that a trade war might be imminent.

 
Wall Street rises on trade war truce; industrials lead

3h moneycontrol
US stocks rose on Monday and gains in industrials helped propel the Dow to a more than two-month closing high, after a truce between the United States and China calmed fears that a trade war might be imminent.

 
General Electric Company Has Taken the First Step Towards Recovery

7h investorplace
General Electric Company (NYSE:GE) is finally doing what analysts expected, even demanded it do after John Flannery became CEO last year.

 
Business Highlights

7h nzherald.co.nz
WASHINGTON (AP) — A divided Supreme Court has ruled that businesses can prohibit their workers from banding together in disputes over pay and conditions in the workplace, a decision that affects an estimated 25 million non-unionized employees. With the court's five conservative members in the majority, the justices held that individual employees can be forced to use arbitration, not the courts, to air complaints about wages and overtime.

 
Top Stock Picks for the Week of May 21, 2018

8h zacks
General Electric (GE - Free Report) shares hit a new decades-low in 2018 as the company instituted a new turnaround plan. With its announcement of its deal with Wabtec, are the pieces starting to fall into place? This Zacks Rank #3 (Hold) is off its lows. Find out why Sheraz thinks it’s a buy right now.

 
General Electric, Alphabet and Micron Technology surge

8h nzherald.co.nz
The conglomerate will get $2.9 billion as it combines its train engine business with Westinghouse Air Brake Technologies.

 
GE merges transportation unit with Wabtec in US$11.1b deal

9h channelnewsasia
NEW YORK: General Electric Co confirmed on Monday (May 21) it was unloading the bulk of its transportation business which makes train engines to Wabtec Corp , a US manufacturer of equipment for the rail industry, in a deal valued at about US$11.1 billion.

 
Wall Street forges higher on China-US trade truce cheer

9h channelnewsasia
NEW YORK: Wall Street started the week with a rally on Monday (May 21), sending stocks higher as investors heaved a sigh of relief that Washington and Beijing had decided to step back from a possible trade war.

 
Boeing, Caterpillar Lift the Dow Monday

10h 247wallst
May 21, 2018: Markets opened higher Monday following a weekend where tensions with China over tariffs and trade eased substantially even though no final deal appears to be near. 10-Year Treasury yields remain above 3% and the dollar traded higher. All equity sectors except healthcare were trading higher as Monday’s regular session wound down.

 
GE And Wabtec Merger: Good News Already Priced In

10h seekingalpha
The company will own a 50% stake in the business, although much ends up directly in the hands of GE shareholders.

 
GE: The Real Problem

10h seekingalpha
There are broad theories about whether or not GE can actually steer the course and remain viable into this new millennium - and legitimate questions exist on both sides.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

12h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

12h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

22h - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...